Skip to main content
. 2010 Aug 27;49(12):2381–2390. doi: 10.1093/rheumatology/keq277

Table 4.

Reported drug therapies in children with JIIM within 6 months of illness onset

Age at diagnosis
Drug exposure JIIM (n = 285), n (%) ≤7.5 years (n = 150), n (%) >7.5 years (n = 135), n (%)
None 237 (83) 125 (83) 112 (83)
No. of patients exposed 48 (17) 25 (17) 23 (17)
No. of drug exposures
    1 38 (79) 24 (96)* 14 (61)*
    2 6 (13) 0 (0) 6 (26)
    3 4 (8) 1 (4) 3 (13)
    Total 62 27 35
Type of druga
    Potentially myopathic only 3 (5) 0 (0) 3 (9)
    Potentially photosensitizing only 3 (5) 0 (0) 3 (9)
    Potentially myopathic and photosensitizing 11 (18) 5 (19) 6 (17)
    Not myopathic or photosensitizing 31 (50.0) 13 (48) 18 (51)
    Unknown type 14 (22) 9 (33) 5 (14)

Conventions as per Table 2. Bold values represent P ≤ 0.05 after Holm’s adjustment for multiple comparisons (using family-wise error rates of 5%). aBased on total number of drug exposures, because some patients had >1 documented drug exposure. Potentially myopathic drugs included penicillin (n = 2) and ranitidine (n = 1) [28–31]. Potentially photosensitizing drugs included loratadine (n = 1), diphenhydramine (n = 1) and sertaline (n = 1) [26, 27]. Drugs classified as potentially both myopathic and photosensitizing included ibuprofen (n = 5), trimethroprim/sulphamethoxazole (n = 3), isoniazid (n = 2) and erythromycin–sulfisoxazole (n = 1). Drugs not known to be either myopathic or photosensitizing included amoxicillin (n = 4), cefaclor (n = 3), pseudoephedrine (n = 2), cetirizine (n = 1), albuterol inhaler (n = 1), flecainide (n = 1), bromopheniramine maleate (n = 1), nedocromil (n = 1), oxybutynin (n = 1), permethrin (n = 1), pyrethrine (n = 1), cantharidine (n = 1), cefadroxil (n = 1), acetaminophen (n = 1), streptomycin (n = 1), erythromycin (n = 1) and nystatin (n = 1). Drugs whose classification is unknown included unknown antibiotic (n = 10), birth control (n = 3) and anaesthetic (n = 1). *P = 0.004; OR 15.4; 95% CI 1.8, 135. †P = 0.008 ; OR 18.9; 95% CI 1.0, 358.